Summary & Overview

HCPCS S9346: Home Infusion Administrative Services for Alpha-1 Therapy

HCPCS Level II code S9346 designates per diem administrative and professional pharmacy services for home infusion of alpha-1-proteinase inhibitor products (example: Prolastin). This code captures care coordination, pharmacy oversight, and required supplies and equipment needed to support home-based infusions while the drug product and nursing services are billed separately. Nationally, home infusion codes such as S9346 matter because they delineate non-drug professional services that support specialty biologic therapies delivered outside traditional settings, affecting site-of-care planning and payer coverage policies.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the clinical service and site of care, typical billing structure (per diem administrative services vs. separately billed drug and nursing lines), and implications for payer coverage and claims processing. The publication also outlines benchmarks and policy considerations relevant to home infusion administration, common modifiers used on related claims, and operational notes for providers and payers handling alpha-1-proteinase inhibitor infusions in the home setting.

Data not available in the input is noted where applicable.

AetnaBlue Cross Blue ShieldCigna HealthUnitedHealthcareMedicareS9346HCPCS Level IIhome infusionalpha-1-proteinase inhibitorprofessional pharmacy servicescare coordinationper diemoutpatient infusion

Billing Code Overview

HCPCS Level II code S9346 describes home infusion therapy administrative services for alpha-1-proteinase inhibitor products (for example, Prolastin). The code covers professional pharmacy services, care coordination, and all necessary supplies and equipment associated with home infusion administration; the infused drug product and nursing visits are billed separately.

Service Type: Home infusion therapy administrative and professional pharmacy services

Typical Site of Service: Patient home (home-based infusion therapy)

Data not available in the input.

Clinical & Coding Specifications

Clinical Context

A typical patient is an adult with confirmed alpha-1 antitrypsin deficiency and clinically significant emphysema who requires weekly home infusion of alpha-1-proteinase inhibitor (A1PI) replacement therapy. The patient is referred by a pulmonologist following genotyping and pulmonary function testing that demonstrate accelerated decline in FEV1 and radiographic/emphysematous changes. A home infusion pharmacy coordinates logistics, obtains prior authorization from payors (for example, Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, BUCA, and Medicare), schedules a licensed infusion nurse, supplies infusion equipment and disposables, and documents each per-diem administrative service under S9346. The actual drug product (e.g., Prolastin) is billed separately by NDC or J-code, nursing visits are billed with appropriate home health or infusion visit CPT/HCPCS codes, and any laboratory monitoring (alpha-1 levels, infectious disease screening) is ordered by the clinician and billed separately.

Typical workflow:

Referral and prior authorization initiated by the pulmonologist.
Home infusion pharmacy verifies diagnosis, establishes plan of care, and coordinates nursing visits and infusion schedule.
Pharmacy delivers A1PI drug (billed separately), disposables, infusion pump if required, and documents per-diem administrative services under S9346 for care coordination, professional pharmacy services, and supplies/equipment (excluding drug and nursing visit charges).
Licensed nurse performs home infusion visits, monitors for infusion reactions, documents vitals and adverse events, and communicates with the ordering clinician.
Ongoing monitoring includes pulmonary follow-up, periodic pulmonary function tests, and insurance reauthorization as required.

Coding Specifications

Modifier	Description	When to Use
`22`	Increased procedural services	Use when substantial additional work or complexity in administering home infusion coordination beyond typical care (rare for per-diem administrative billing).
`52`	Reduced services	Use if the per-diem administrative services were partially furnished or limited on a given day.
`53`	Discontinued procedure	Use when services are started but discontinued due to patient instability or other immediate contraindication.
`59`	Distinct procedural service	Use to indicate a separate and distinct service when billing other concurrent services that might be bundled with administrative care.
`76`	Repeat procedure or service by same physician/provider	Use when per-diem administrative services are billed more than once for a repeated service on the same day by the same provider.
`78`	Unplanned return to the operating/procedure room by same physician/provider following initial procedure for a related procedure during the postoperative period	Rarely used; applicable if an unplanned, related procedural intervention occurs following initial infusion-related complication.
`KX`	Requirements specified in the medical policy are met	Use when payer-specific policy criteria for A1PI therapy are met and documented (authorization prerequisites satisfied).
`QX`	Ordering/servicing physician and clinical staff billing for supervision of services performed by a qualified non-physician practitioner	Use when applicable supervision rules apply for home infusion services.
`QY`	Attending provider with primary responsibility for care of the beneficiary	Use per payer rules to indicate the attending provider’s billing relationship when required.
`GY`	Item or service statutorily excluded, does not meet the definition of any Medicare benefit, or is not reasonable and necessary	Use when payor denies coverage as non-covered under specific benefit rules.
`AS`	Physician services when performed in part B for beneficiaries under TRICARE/CHAMPVA	Use per payor rules where applicable for alternate payor scenarios.
`SC`	Service provided in a specialty type clinic	Use if administrative services are performed under a certified specialty infusion clinic model.
`SD`	Services rendered as part of disaster response	Use in declared disaster situations when standard operations are modified.
`QK`	Medical direction by a physician: more than four concurrent anesthesia procedures	Typically not applicable; included for completeness if anesthesia medical direction interfaces with infusion sedation.

Taxonomy Code	Specialty	Notes
`165W00000X`	Home Infusion Therapy Provider	Pharmacy or infusion provider specializing in home infusion administrative services and coordination.
`207RH0000X`	Pulmonology	Ordering specialty for alpha-1-proteinase inhibitor therapy and ongoing pulmonary management.
`333600000X`	Registered Nurse (RN)	Clinical staff performing home infusion administration and patient monitoring.
`363A00000X`	Clinical Pharmacy Specialist	Pharmacist overseeing drug therapy management, prior authorization, and medication safety.
`261QM1800X`	General Practice/Family Medicine	Primary care providers who may coordinate care and referrals for home infusion therapy.

ICD-10 Code	Description	Clinical Relevance
`E88.01`	Alpha-1 antitrypsin deficiency	Primary indication for alpha-1-proteinase inhibitor replacement therapy.
`J43.9`	Emphysema, unspecified	Common pulmonary manifestation in patients with alpha-1 antitrypsin deficiency requiring augmentation therapy.
`J44.9`	Chronic obstructive pulmonary disease, unspecified	COPD diagnosis often present in patients receiving A1PI therapy for emphysema related to alpha-1 deficiency.
`R06.02`	Shortness of breath	Symptom commonly monitored during infusion therapy and follow-up.
`Z79.899`	Other long term (current) drug therapy	Denotes ongoing long-term therapy status for chronic A1PI replacement.

CPT Code	Description	Relationship to This Procedure
`99213`	Office or other outpatient visit for the evaluation and management of an established patient, typically 15 minutes	Used for routine outpatient follow-up visits by the ordering clinician to assess therapy response and authorization documentation.
`96365`	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	Used when a nursing visit provides the active intravenous infusion of A1PI (if billed separately for nursing infusion time).
`99406`	Smoking and tobacco use cessation counseling visit, intermediate, greater than 3 minutes up to 10 minutes	Often performed in pulmonary patients; billed separately when provided as part of counseling during follow-up.
`36415`	Collection of venous blood by venipuncture	Used when blood is drawn for laboratory monitoring related to therapy (e.g., serology, baseline labs).
`99051`	Services provided in the evening, weekend, or holiday, in addition to basic service	May be used when administrative or nursing services are furnished during atypical hours in coordination with home infusion.
`G0299`	Physician or other qualified healthcare professional direction of a complex, high-risk home infusion therapy service requiring daily skilled nursing visits and physician supervision	Used when payer recognizes a supervision/direction code for complex home infusion programs; complements `S9346` administrative per-diem billing.

OpenPayer